Publicaciones en colaboración con investigadores/as de New York University School of Medicine (17)

2024

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials(Nature Communications, (2021), 12, (1), 10.1038/s41467-021-22446-z)

    Nature Communications

  2. International Pooled Analysis of Leisure-Time Physical Activity and Premenopausal Breast Cancer in Women From 19 Cohorts

    Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 42, Núm. 8, pp. 927-939

2023

  1. From old pollutants to the regulation of bisphenol A: Lessons learned for health promotion and disease prevention

    Preventive Medicine

  2. Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

    Journal of the National Cancer Institute, Vol. 115, Núm. 9, pp. 1050-1059

2021

  1. Author Correction: Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials (Nature Communications, (2021), 12, 1, (2349), 10.1038/s41467-021-22446-z)

    Nature Communications

  2. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials

    Nature Communications, Vol. 12, Núm. 1

2020

  1. Cumulative Burden of Colorectal Cancer–Associated Genetic Variants Is More Strongly Associated With Early-Onset vs Late-Onset Cancer

    Gastroenterology, Vol. 158, Núm. 5, pp. 1274-1286.e12

2019

  1. Ovarian cancer risk factors by tumor aggressiveness: An analysis from the Ovarian Cancer Cohort Consortium

    International Journal of Cancer, Vol. 145, Núm. 1, pp. 58-69

2018

  1. Risk prediction for estrogen receptor-specific breast cancers in two large prospective cohorts 11 Medical and Health Sciences 1117 Public Health and Health Services

    Breast Cancer Research, Vol. 20, Núm. 1

2017

  1. Biomarkers of folate and vitamin B12 and breast cancer risk: report from the EPIC cohort

    International Journal of Cancer, Vol. 140, Núm. 6, pp. 1246-1259

  2. Demographic, lifestyle, and other factors in relation to antimüllerian hormone levels in mostly late premenopausal women

    Fertility and Sterility, Vol. 107, Núm. 4, pp. 1012-1022.e2

2016

  1. Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer

    Nature Communications, Vol. 7

2015

  1. Pre-diagnostic polyphenol intake and breast cancer survival: the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort

    Breast Cancer Research and Treatment, Vol. 154, Núm. 2, pp. 389-401

2010

  1. Obesity, inflammatory markers, and endometrial cancer risk: A prospective case - control study

    Endocrine-Related Cancer, Vol. 17, Núm. 4, pp. 1007-1019

  2. Pancreatic cancer risk and ABO blood group alleles: Results from the Pancreatic Cancer Cohort Consortium

    Cancer Research, Vol. 70, Núm. 3, pp. 1015-1023

  3. Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: Results from the pancreatic cancer cohort consortium

    Cancer Epidemiology Biomarkers and Prevention, Vol. 19, Núm. 12, pp. 3140-3149

2007

  1. Plasma adiponectin levels and endometrial cancer risk in pre- and postmenopausal women

    Journal of Clinical Endocrinology and Metabolism, Vol. 92, Núm. 1, pp. 255-263